MedTrace Logo

Tumoral Circulating Cells and Colorectal Cancer Progression

NCT03256084 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-05-06

No results posted yet for this study

Summary

Prospective research of circulating tumor cells as markers of progression risk in colorectal cancer.

Conditions

Interventions

PROCEDURE

Blood and tumor samples

Blood and tumor samples

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Beckman Coulter, Inc.

    collaborator INDUSTRY

  • Institut Paoli-Calmettes

    lead OTHER

Principal Investigators

  • Jean-Luc RAOUL, Pr · Institut Paoli-Calmettes

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-17
Primary Completion
2022-05-31
Completion
2025-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03256084 on ClinicalTrials.gov